GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OSTO:BIOT) » Definitions » Beneish M-Score

Biotage AB (OSTO:BIOT) Beneish M-Score : -2.29 (As of May. 17, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biotage AB Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.29 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Biotage AB's Beneish M-Score or its related term are showing as below:

OSTO:BIOT' s Beneish M-Score Range Over the Past 10 Years
Min: -3.05   Med: -2.52   Max: -1.98
Current: -2.29

During the past 13 years, the highest Beneish M-Score of Biotage AB was -1.98. The lowest was -3.05. And the median was -2.52.


Biotage AB Beneish M-Score Historical Data

The historical data trend for Biotage AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Beneish M-Score Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.38 -2.85 -2.67 -2.30 -2.09

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.41 -1.98 -2.20 -2.09 -2.29

Competitive Comparison of Biotage AB's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Biotage AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Biotage AB's Beneish M-Score falls into.



Biotage AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Biotage AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9253+0.528 * 0.9691+0.404 * 1.3289+0.892 * 1.2855+0.115 * 1.0547
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0353+4.679 * -0.034972-0.327 * 0.8473
=-2.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was kr364 Mil.
Revenue was 480 + 643 + 449 + 409 = kr1,981 Mil.
Gross Profit was 303 + 393 + 282 + 253 = kr1,231 Mil.
Total Current Assets was kr1,490 Mil.
Total Assets was kr5,147 Mil.
Property, Plant and Equipment(Net PPE) was kr292 Mil.
Depreciation, Depletion and Amortization(DDA) was kr168 Mil.
Selling, General, & Admin. Expense(SGA) was kr728 Mil.
Total Current Liabilities was kr691 Mil.
Long-Term Debt & Capital Lease Obligation was kr367 Mil.
Net Income was 33 + 131 + 38 + 34 = kr236 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0 Mil.
Cash Flow from Operations was 108 + 154 + 103 + 51 = kr416 Mil.
Total Receivables was kr306 Mil.
Revenue was 361 + 384 + 401 + 395 = kr1,541 Mil.
Gross Profit was 220 + 227 + 241 + 240 = kr928 Mil.
Total Current Assets was kr1,034 Mil.
Total Assets was kr2,362 Mil.
Property, Plant and Equipment(Net PPE) was kr166 Mil.
Depreciation, Depletion and Amortization(DDA) was kr104 Mil.
Selling, General, & Admin. Expense(SGA) was kr547 Mil.
Total Current Liabilities was kr377 Mil.
Long-Term Debt & Capital Lease Obligation was kr196 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(364 / 1981) / (306 / 1541)
=0.183746 / 0.198572
=0.9253

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(928 / 1541) / (1231 / 1981)
=0.602206 / 0.621403
=0.9691

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1490 + 292) / 5147) / (1 - (1034 + 166) / 2362)
=0.653779 / 0.491956
=1.3289

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1981 / 1541
=1.2855

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(104 / (104 + 166)) / (168 / (168 + 292))
=0.385185 / 0.365217
=1.0547

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(728 / 1981) / (547 / 1541)
=0.367491 / 0.354964
=1.0353

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((367 + 691) / 5147) / ((196 + 377) / 2362)
=0.205557 / 0.242591
=0.8473

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(236 - 0 - 416) / 5147
=-0.034972

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Biotage AB has a M-score of -2.29 suggests that the company is unlikely to be a manipulator.


Biotage AB Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Biotage AB's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (OSTO:BIOT) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (OSTO:BIOT) Headlines

From GuruFocus